Synlett 2024; 35(09): 1052-1056
DOI: 10.1055/a-2216-4710
cluster
Chemical Synthesis and Catalysis in Germany

Organocatalytic, Chemoselective, and Stereospecific House–Meinwald Rearrangement of Trisubstituted Epoxides

,
,
Christopher Topp
,
This work was supported by the Justus Liebig University.


Abstract

We present a novel method for the chemoselective House–Meinwald rearrangement of trisubstituted epoxides under mild conditions with the use of simple perfluorinated disulfonimides as Brønsted acid catalysts. We isolated the α-quaternary aldehyde products in yields of 27–97% using catalyst loadings as low as 0.5 mol% on a scale of 1 mmol. In addition, we show the stereospecific rearrangement using an enantioenriched substrate, which makes this method suitable for applications in total synthesis of natural products.

Supporting Information

Primary Data



Publication History

Received: 18 October 2023

Accepted after revision: 22 November 2023

Accepted Manuscript online:
22 November 2023

Article published online:
05 January 2024

© 2023. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References and Notes

  • 2 Li C, Ragab SS, Liu G, Tang W. Nat. Prod. Rep. 2020; 37: 276
  • 5 Kumar R, Halder J, Nanda S. Tetrahedron 2017; 73: 809
  • 6 Vital P, Tanner D. Org. Biomol. Chem. 2006; 4: 4292
  • 7 Bando T, Shishido K. Chem. Commun. 1996; 1357
  • 8 Jung ME, D'Amico DC. J. Am. Chem. Soc 1995; 117: 7379
  • 9 Martínez F, Del Campo C, Llama EF. J. Chem. Soc., Perkin Trans. 1 2000; 1749
  • 10 Suda K, Baba K, Nakajima S.-i, Takanami T. Tetrahedron Lett. 1999; 40: 7243
  • 11 Liu W, Leischner T, Li W, Junge K, Beller M. Angew. Chem. Int. Ed. 2020; 59: 11321
  • 12 Robinson MW. C, Pillinger KS, Mabbett I, Timms DA, Graham AE. Tetrahedron 2010; 66: 8377
  • 14 Ranu BC, Jana U. J. Org. Chem. 1998; 63: 8212
  • 15 Procopio A, Dalpozzo R, De Nino A, Nardi M, Sindona G, Tagarelli A. Synlett 2004; 2633
  • 16 Karamé I, Tommasino ML, Lemaire M. Tetrahedron Lett. 2003; 44: 7687
  • 17 Anderson AM, Blazek JM, Garg P, Payne BJ, Mohan RS. Tetrahedron Lett. 2000; 41: 1527
  • 20 Hrdina R, Müller CE, Wende RC, Lippert KM, Benassi M, Spengler B, Schreiner PR. J. Am. Chem. Soc. 2011; 133: 7624
  • 21 Suda K, Nakajima S.-i, Satoh Y, Takanami T. Chem. Commun. 2009; 1255
  • 24 Kütt A, Tshepelevitsh S, Saame J, Lõkov M, Kaljurand I, Selberg S, Leito I. Eur. J. Org. Chem. 2021; 1407
  • 25 Raamat E, Kaupmees K, Ovsjannikov G, Trummal A, Kütt A, Saame J, Koppel I, Kaljurand I, Lipping L, Rodima T, Pihl V, Koppel IA, Leito I. J. Phys. Org. Chem. 2013; 26: 162
  • 27 (C6F5SO2)2NH-Catalyzed Rearrangement of Trisubstituted Epoxides 1.0 mmol epoxide was dissolved in 10 mL (CH2Cl)2, and 12.0 mg (0.025 mmol, 2.5 mol%) (C6F5SO2)2NH was added. The reaction mixture was heated to 83 °C for the indicated time, then cooled to room temperature and quenched with 10 mL saturated NaHCO3 solution. The aqueous phase was extracted with CH2Cl2 (3 × 15 mL). The combined organic phases were dried over MgSO4, and the solvent was removed under reduced pressure. Purification by column chromatography afforded the product.
  • 28 Prileschajew N. Ber. Dtsch. Chem Ges. 1909; 42: 4811
  • 29 Zhou S, Tu X, He Y, Gao L, Song ZL. Eur. J. Org. Chem. 2022; e202200766
  • 30 Tf2NH-Catalyzed Rearrangement of Trisubstituted Epoxides 1.0 mmol epoxide was dissolved in 10 mL CH2Cl2, and 7.0 mg (0.025 mmol, 2.5 mol%) Tf2NH was added. The reaction mixture was stirred at room temperature for the indicated time and then quenched with 10 mL saturated NaHCO3 solution. The aqueous phase was extracted with CH2Cl2 (3 × 5 mL). The combined organic phases were dried over MgSO4, and the solvent was removed under reduced pressure. Purification by column chromatography afforded the product.
  • 31 1-(4-Benzoic Acid Methyl Ester)cyclopentanecarbaldehyde (11) Via Method B and 2 h reaction time; yield 191 mg (0.822 mmol, 82%); Rf = 0.25 (n-hexane/ethyl acetate, 20:1). 1H NMR (400 MHz, CDCl3): δ = 9.41 (s, 1 H), 8.03–8.00 (m, 2 H), 7.37–7.29 (m, 2 H), 3.91 (s, 3 H), 2.60–2.49 (m, 2 H), 1.95–1.86 (m, 2 H), 1.83–1.62 (m, 4 H) ppm. 13C NMR (101 MHz, CDCl3): δ = 200.2, 166.9, 145.7, 130.1, 127.8, 64.1, 52.3, 32.7, 24.4 ppm. IR (ATR): 2952 (w), 2873 (w), 1716 (s), 1608 (w), 1435 (m), 1275 (s), 1186 (m), 1018 (m), 770 (m), 706 (m) cm–1. HRMS (ESI): m/z calcd for C14H16O3Na+: 255.0991; found: 255.0991 [M + Na]+.
  • 32 1-(4-Cyanophenyl)cyclopentanecarbaldehyde (12) Via Method B and 2 h reaction time; yield 146 mg (0.733 mmol, 73%); Rf = 0.20 (n-hexane/ethyl acetate, 20:1). 1H NMR (400 MHz, CDCl3): δ = 9.39 (s, 1 H), 7.64 (dd, J = 8.7, 1.9 Hz, 3 H), 7.36 (dd, J = 8.7, 1.9 Hz, 3 H), 2.56–2.49 (m, 2 H), 1.93–1.84 (m, 4 H), 1.82–1.63 (m, 6 H) ppm. 13C NMR (101 MHz, CDCl3): δ = 199.7, 145.9, 132.6, 128.6, 118.7, 111.2, 64.1, 32.7, 24.3 ppm. IR (ATR): 3364 (m), 2954 (m), 2874 (w), 2235 (m), 1607 (m), 1403 (m), 833 (s), 566 (s) cm–1. HRMS (ESI): m/z calcd for C13H13NONa+: 222.0889; found: 222.0890 [M + Na]+.
  • 33 1-(4-Nitrophenyl)cyclopentanecarbaldehyde (13) Via Method B and 2 h reaction time; yield 160 mg (0.730 mmol, 75%); Rf = 0.22 (n-hexane/ethyl acetate, 10:1). 1H NMR (400 MHz, CDCl3): δ = 9.43 (s, 1 H), 8.21 (dd, J = 8.9, 2.1 Hz, 2 H), 7.43 (dd, J = 8.9, 2.1 Hz, 2 H), 2.61–2.53 (m, 2 H), 1.98–1.89 (m, 2 H), 1.85–1.65 (m, 5 H) ppm. 13C NMR (101 MHz, CDCl3): δ = 199.6, 148.0, 147.2, 128.7, 124.0, 64.1, 33.0, 24.4 ppm. IR (ATR): 3108 (w), 3080 (w), 2944 (m), 1720 (s), 1595 (m), 1513 (s), 1347 (s) 1317 (m), 1108 (m), 851 (m), 748 (m), 696 (s) cm–1. HRMS (ESI): m/z calcd for C12H13NO3Na+: 242.0787; found: 242.0790 [M + Na]+.
  • 34 Nagai Y, Hino K, Uno H, Minami S. Chem. Pharm. Bull. 1980; 1387
  • 35 Wang Z.-X, Tu Y, Frohn M, Zhang J.-R, Shi Y. J. Am. Chem. Soc. 1997; 119: 11224
  • 36 Ethyl-(3R)-(3-phenyl-3-formyl-1-pyrrolidinecarboxylate) ((R)-14) Via Method B on a 1.5 mmol scale with 0.5 mol% catalyst and 15 min reaction time; yield 360 mg (1.46 mmol, 97%); Rf = 0.22 (n-hexane/ethyl acetate, 5:1). 1H NMR (400 MHz, CDCl3): δ = 9.45 (s, 1 H), 7.44–7.37 (m, 2 H), 7.36–7.30 (m, 1 H), 7.24–7.17 (m, 2 H), 4.47–4.35 (m, 1 H), 4.22–4.09 (m, 2 H), 3.70–3.47 (m, 2 H), 3.35 (td, J = 10.7, 6.9 Hz, 1 H), 2.81 (br s, 1 H), 2.21 (q, J = 10.7 Hz, 1 H), 1.63 (br s, 1 H), 1.31–1.24 (m, 3 H) ppm. 13C NMR (101 MHz, CDCl3): δ = 198.0, 155.1, 136.3, 129.4, 128.3, 127.4, 106.3, 61.4, 50.2, 44.8, 30.8, 14.9 ppm. IR (ATR): 2989 (w), 2878 (w), 2809 (w), 1718 (m), 1694 (s), 1419 (s), 1380 (m), 1354 (m), 1341 (m), 1103 (m), 1024 (m), 888 (w), 769 (m), 759 (m), 699 (m) cm−1. HRMS (ESI): m/z calcd for C14H17NO3Na+: 270.1100; found: 270.1102 [M + Na]+. HPLC: Chiralpak IC (n-hexane/2-propanol, 70:30 v/v, 1 mL/min, 30 min run time), fraction 1: t R = 11.59 min, fraction 2: t R = 14.65 min.